Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

Nvidia stomps the bears. Plus, Cramer’s thoughts on 2 struggling portfolio names

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

Jim Cramer: It’s not too late to buy this portfolio health-care stock after Friday’s selloff

Jim Cramer: It’s not too late to buy this portfolio health-care stock after Friday’s selloff

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. U.S. stocks jumped Monday as the Nasdaq and S & P 500 attempts to recover from back-to-back weekly losses. Major gains … Read more

Experts hesitate on weight loss ETFs amid the obesity drug boom

Experts hesitate on weight loss ETFs amid the obesity drug boom

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week to launch funds focused on weight loss companies, a move that Strategas ETF and technical strategist … Read more

The news hitting a portfolio health-care name actually removes an overhang on the stock

The news hitting a portfolio health-care name actually removes an overhang on the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday following Tuesday’s record high close for the S & P 500 on a rebound in the … Read more

Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips

Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 5% on Thursday morning, according to LSEG data, hitting a fresh record highs after the Danish pharmaceutical giant reported positive early trial data for a new experimental weight loss drug. The company told an investor … Read more

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

One down one to go — what we learned from TJX’s great quarter and hope to hear from Salesforce

One down one to go — what we learned from TJX’s great quarter and hope to hear from Salesforce

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. U.S. stocks were trending lower as investors awaited important inflation data and mulled over more quarterly earnings. January’s PCE price … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

In this fast-paced bull market, we’re increasing our Club price targets on 4 stocks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s been hard to keep up. That’s the story of the big stock winners this year. They just keep winning and winning and winning. For analysts on Wall Street and here at the Club, it seems like some of these names are smashing through our six-to-nine-month … Read more

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

Here’s why we would be considering buying more Eli Lilly shares if they were down Tuesday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday on hotter-than-expected retail inflation data. The surprise uptick in the January consumer price index sent bond … Read more

Wall Street changes its tune on this healthcare stock. Why we were always bullish

Wall Street changes its tune on this healthcare stock. Why we were always bullish

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were modestly higher Monday as the market awaits key economic data. Traders will be mulling over the consumer … Read more

Portfolio health care name turns its luck around thanks to management’s AI push

Portfolio health care name turns its luck around thanks to management’s AI push

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. U.S. stocks were mostly higher on Friday. The S & P 500 was on track for a fifth positive week … Read more

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

Wall Street gives 2 of our healthcare stocks well-deserved price target bumps

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round of well-deserved price target bumps for the Club stocks. Analysts at four equity research firms boosted their price targets for GE Healthcare since the maker of … Read more

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

GEHC stock finally gets some respect after earnings. Those betting against it got slammed

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns about China. That coupled with management’s upbeat view of this year propelled shares up more than 13% to over $83 each at session highs. That was their highest level since July … Read more

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

Wall Street says Big Tech needs to take a breather after huge run. Here’s our take

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks were mixed Tuesday, on a muted performance from Big Tech. Citigroup strategists warned that tech stocks may stall … Read more

January was great for stocks — here are the top 5 performers in the portfolio

January was great for stocks — here are the top 5 performers in the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Benchmark gauges notched all-time highs as stocks charged through a busy earnings season. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

We’re trimming a health-care stock ahead of earnings — hedging our bets on business in China

We’re trimming a health-care stock ahead of earnings — hedging our bets on business in China

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re selling 95 shares of GE Healthcare at roughly $74. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,150 shares of GEHC, reducing its weighting to 2.75% from 2.97%. The small trim we’re making in GE Healthcare with the stock up slightly in an otherwise … Read more

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Liselotte Sabroe | Afp | Getty Images Novo Nordisk, Europe’s largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and diabetes drug Ozempic reported … Read more

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

Why we like health-care stocks in 2024 despite their spotty record in presidential election years

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

Walgreens and 3 other health-care stocks are going into our Bullpen watch list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re making our first Bullpen update of 2024. The Bullpen is a collection of stocks identified by the CNBC Investing Club team as having the potential to join Jim Cramer’s Charitable Trust. We’re highlighting the four most interesting investment opportunities we found out of the handful … Read more

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three … Read more

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

New data on Eli Lilly’s weight-loss drug confirms its outlook is still bright

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the … Read more

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company’s obesity drug Zepbound. The situation seems rather clear-cut to us: It’s no reason to sell. Eli Lilly shares on Tuesday shook off afternoon losses to … Read more

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

Flying solo without Cigna will keep Humana focused on 2 big priorities in the year ahead

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It looks like Cigna has scrapped its takeover bid for Club holding Humana , removing a dark cloud over both stocks that’s lingered since the acquisition talks surfaced nearly two weeks ago. Cigna and Humana were unable to agree on an acquisition price and other financial … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

Why Pfizer’s latest stumble in the obesity market is a boon for Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss … Read more

Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators

Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer urged Humana (HUM) not to pursue a merger with rival health insurer Cigna (CI), questioning the merits of a potential business combination and the likelihood of it passing U.S. antitrust review. Cigna and Humana could reach an agreement on a stock-and-cash transaction by the … Read more

Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Wall Street was mixed Monday after the Dow , the S & P 500 and the Nasdaq finished higher for … Read more

Amazon adds a new reason to get and keep Prime: member discounts on health-care services

Amazon adds a new reason to get and keep Prime: member discounts on health-care services

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amazon (AMZN) said on Wednesday that it’s offering Prime members a discount on its new health-care service — another perk that should help bring more people into the online retailer’s ecosystem. The One Medical service, which typically costs $199 annually, will be available to Prime subscribers … Read more

The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock

The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter. Revenue for the … Read more

We had a busy week of trades in an oversold market. Here’s the day-by-day breakdown

We had a busy week of trades in an oversold market. Here’s the day-by-day breakdown

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Elevated bond yields and geopolitical uncertainty continued to be negative for stocks this week as the overall market moved into oversold territory. However, that set us up to put cash to work and make four small buys as our discipline mandates. We also upgraded one of … Read more

We’re buying more of this life sciences stock after an earnings-driven decline

We’re buying more of this life sciences stock after an earnings-driven decline

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The stock is under pressure in early trading due to uncertainty around the recovery in a key business. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

When is it OK to violate your cost basis to buy more shares of a company?

When is it OK to violate your cost basis to buy more shares of a company?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant … Read more

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical trades for earnings season. Asset allocation can be strategic or tactical. Strategic asset allocation generally refers to longer-term investing — think of this as your buy-and-hold approach. … Read more

Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials

Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the October Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their answers have been edited for clarity. 1. Why do rising interest rates have such a negative effect on technology stocks? (Rod) … Read more

Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’

Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE CNBC’s Jim Cramer on Wednesday praised the incoming CEO of Walgreens Boots Alliance, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services. “This guy is the real deal. I just salute him … Read more

15 stocks with a history of dividend growth are expected to deliver once again this year

15 stocks with a history of dividend growth are expected to deliver once again this year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue in their current fiscal years. Long-term investors should look to own companies with a history of dividend growth instead … Read more

Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’

Cramer says Vertex has a drug that may address the ‘largest market opportunity in the world’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer on Squawk on the Street, June 30, 2022. Virginia Sherwood | CNBC CNBC’s Jim Cramer on Monday suggested that investors keep an eye on Vertex Pharmaceuticals (VRTX), a biotechnology company developing a drug to treat acute pain that is not an opioid. “The biggest … Read more

Here are all the portfolio moves the Club made in this week’s oversold market

Here are all the portfolio moves the Club made in this week’s oversold market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE With the stock market deeply oversold this week, we put cash to work by picking stocks across a range of sectors including energy, technology and materials. We also added a former Club chipmaker to our Bullpen and upgraded a premium beer name to a buy rating. … Read more

We’re booking some profits on this health insurance stock after waiting out its slump

We’re booking some profits on this health insurance stock after waiting out its slump

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

It’s time to get bullish on this health tech name, now that it’s shed a drag on growth

It’s time to get bullish on this health tech name, now that it’s shed a drag on growth

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We care much more about where a stock is going than where it’s been. With the spin-off of Veralto (VLTO) complete, we decided to look at the path ahead for Danaher (DHR) — now free of its slower-growing, lower-margin water business. In the separation , we … Read more

We’re set to receive shares in Danaher’s separated water business. Here’s our plan for the new stock

We’re set to receive shares in Danaher’s separated water business. Here’s our plan for the new stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Danaher (DHR) is days away from shedding its environmental-and-applied solutions segment, and the Club holding’s ability to deliver returns for shareholders appears stronger than ever. Those potential returns can come from two places: Danaher stock and shares of Veralto (VLTO), the soon-to-be-standalone company that’s in the … Read more

Health care has had a tough year. Where we stand on our 5 stocks in the sector

Health care has had a tough year. Where we stand on our 5 stocks in the sector

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been a challenging period for the industry overall. Of the 11 market sectors year to date, health care … Read more

Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buy

Here’s a rapid-fire update on all 35 stocks in the Club’s portfolio, including a new buy

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here are the risks to alcohol and food stocks from Ozempic-like weight loss drugs

Here are the risks to alcohol and food stocks from Ozempic-like weight loss drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The rise of new anti-obesity medications could result in less alcohol consumption, impacting Club name Constellation Brands (STZ). The risk already seems to be playing out in food stocks with exposure to snacks and junk food. However, if necessary, the Mexican beer powerhouse behind Corona, Modelo … Read more

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

This health-care stock is set to complete another spin-off. Here’s what it means for our position in the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Medical equipment giant Danaher (DHR) will officially spin off its environmental-and-applied solutions segment later this month, and our plan is to remain invested in the soon-to-be standalone company, known as Veralto, which will trade under the ticker symbol VLTO. That expectation was reinforced Wednesday when Veralto … Read more

Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares

Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

Here are the 8 trades and 3 price-target changes we made during a busy week

Here are the 8 trades and 3 price-target changes we made during a busy week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly results Wednesday evening and Federal Reserve Chairman Jerome Powell’s Jackson Hole address Friday. Here’s a day-by-day look at the trades and price-target changes, and what motivated each decision. Monday Monday proved … Read more

3 things point to better times ahead for this maker of X-Ray and MRI machines

3 things point to better times ahead for this maker of X-Ray and MRI machines

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. 1. Wall Street saw some volatility Friday around Federal Reserve Chairman Jerome Powell’s morning speech from the central bank conference in … Read more

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

This biotech name is one of Jim Cramer’s favorite stocks and he thinks it can go even higher

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the company’s macular degeneration treatment. If you like this story, sign up for Jim Cramer’s Top 10 Morning Thoughts on the Market email newsletter for free. CNBC’s Jim Cramer … Read more

We’re buying more of 2 stocks, deploying some of our cash pile in an oversold market

We’re buying more of 2 stocks, deploying some of our cash pile in an oversold market

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re putting a little more of our big cash position to work Monday into the oversold market. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Here’s a rapid-fire update on all 36 stocks in the Club’s portfolio, including 2 recent buys

Here’s a rapid-fire update on all 36 stocks in the Club’s portfolio, including 2 recent buys

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE During the Investing Club’s August Monthly Meeting, Jim Cramer provided his latest thinking on all 36 names in his Charitable Trust. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting

These are the top 5 performing Club stocks from mid-July to our August Monthly Meeting

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Since the CNBC Investing Club’s July Monthly Meeting, the stock market has seesawed up and then down on a slew of quarterly earnings results and inflation data. That’s left Wall Street struggling this month. Here’s a look at the best performers from the Club’s 36 holdings … Read more

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

Activists ease up on Salesforce — plus, 10 other Club stocks traded by Wall Street pros

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The extraordinary activist-investor interest in Salesforce (CRM) eased further in the second quarter, according to the latest regulatory filings from influential Wall Street pros. These big-name investors also made moves in nine other Club stocks during a strong three-month stretch that ended the best first half … Read more

Eli Lilly gets a new price target after a big rally. Should I buy more shares?

Eli Lilly gets a new price target after a big rally. Should I buy more shares?

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. … Read more

Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week

Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about … Read more

We’re optimistic about this struggling entertainment stock despite an expected weak quarter

We’re optimistic about this struggling entertainment stock despite an expected weak quarter

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Back-to-back losses Still believe in Disney Eli Lilly keeps going 1. Back-to-back losses U.S. stocks on Wednesday were sinking for the … Read more

Here’s what is behind the stock market’s selloff and what we’re doing about it

Here’s what is behind the stock market’s selloff and what we’re doing about it

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Stocks sink Eli Lilly surges Palo Alto slumps 1. Stocks sink U.S. stocks tumbled Tuesday after Moody’s downgraded the credit rating … Read more

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

Here are the 5 price-target changes and 4 trades we made during this busy earnings week

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. … Read more

Troubled health name bounces after strong quarter and guidance. Here’s our view on the stock

Troubled health name bounces after strong quarter and guidance. Here’s our view on the stock

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Troubled Club holding Bausch Health Companies (BHC) reported better-than-expected quarterly results before the bell Thursday. However, it’s not nearly enough to get this stock out of the penalty box. Sales in the second quarter rose 10% to $2.17 billion, exceeding expectations of $2.04 billion, according to … Read more

Humana calms Wall Street’s jitters with quarterly results, clearing way for stock to run higher

Humana calms Wall Street’s jitters with quarterly results, clearing way for stock to run higher

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Revenue for the three months ended June 30 rose 13% year-over-year, to $26.75 billion, exceeding analysts’ estimates … Read more

We’re exiting a health-care name — putting us on the hunt to buy a new stock for the portfolio

We’re exiting a health-care name — putting us on the hunt to buy a new stock for the portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE We’re taking a hard look at the Bullpen and the rest of the market for new opportunities. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Why Cramer Thinks This Retailer Is the ‘Ultimate Downward Trading Play’

Why Cramer Thinks This Retailer Is the ‘Ultimate Downward Trading Play’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Health care at the center of ‘Ultimate trade-down play’ View Bullpen 1 Health care at the center Club holdings Danaher ( … Read more

Warning signs seem to be everywhere in the US. Here’s why they might be pointless

Warning signs seem to be everywhere in the US.  Here’s why they might be pointless

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Warning labels are intended to inform consumers of the potential risks of using a product, but they have become too widespread to be useful. “Warning labels were really rare until the 1960s,” said W. Kip Viscusi, distinguished professor of law, economics and management at Vanderbilt University. … Read more

Here’s what Jim Cramer thinks about J&J stock after the key ruling in the talc case

Here’s what Jim Cramer thinks about J&J stock after the key ruling in the talc case

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A closely watched talc trial in California is going against Johnson & Johnson ( JNJ ), raising uncertainty over whether tens of thousands of other plaintiffs suing the company will sign on to J&J’s proposed $8.9 billion settlement offer or bide their days in court. Jim … Read more

Ford dividend quality, J&J split-off, cost discipline – what we think about it all

Ford dividend quality, J&J split-off, cost discipline – what we think about it all

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Send your questions directly to Jim Cramer and his team of analysts at investingclubmailbag@cnbc.com. A reminder, we cannot provide personal investment advice. We will only consider more general questions about the investment process or the stocks in the portfolio or related industries. Question 1: What is … Read more

J&J’s strong quarter boosted by new details about its large stake in Kenvue’s consumer unit

J&J’s strong quarter boosted by new details about its large stake in Kenvue’s consumer unit

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson ( JNJ ) reported strong second-quarter earnings and revenue ahead of the opening bell on Thursday, with better-than-expected results both domestically and internationally and across all major operating segments. J & J’s sales rose 6.3% year-over-year to $25.53 billion in the second quarter, … Read more

Opting for this specialist supplier could pay off amid strong global demand for oil

Opting for this specialist supplier could pay off amid strong global demand for oil

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE A market capitalization of £386m represents a large discount to the stated book value or net asset value of £665m (or £545m if goodwill is excluded), while the absence of any significant debt should also help protect bad sides. It also means there … Read more

So we are bullish on this mega-cap stock and cautious on this healthcare name

So we are bullish on this mega-cap stock and cautious on this healthcare name

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Earnings and Inflation See J & J Upbeat Outlook for Meta 1 Earnings and Inflation US stocks rose on Monday, with … Read more

Commercial real estate is out of favor right now – but watch this landlord slowly open new doors

Commercial real estate is out of favor right now – but watch this landlord slowly open new doors

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Last month, the FTSE 250 member sold three properties for £49m, including one in Westminster and one in Maidenhead, at an average 7.5 per cent premium to their stated book value (rather than the staggering discount suggested by the share price). This was … Read more

Strong expansion plans for this company are built on solid foundations

Strong expansion plans for this company are built on solid foundations

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE According to rumors, it is rival Travelodge could be up for sale, with the owner, US hedge fund GoldenTree, looking to raise around £1.2bn for the deal. Each transaction could provide a useful valuation benchmark for Whitbread. It will also be interesting to … Read more

How the sky-high cost of living in New York compares to London

How the sky-high cost of living in New York compares to London

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE New York and London are among the most desirable cities to live in because of their many job opportunities and vibrant entertainment options – but residents premium payment. New York is tied with Singapore as most expensive cities in the world in 2022, according to the … Read more

CEOs do matter when picking stocks. 5 things we look for in a leader and examples from our portfolio

CEOs do matter when picking stocks. 5 things we look for in a leader and examples from our portfolio

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s not unusual for a company’s stock price to soar — or sink — on news of a CEO shakeup. When Mary Dillon, revered on Wall Street for her eight-year run at Ulta Beauty (ULTA), was named to the top job at Foot Locker (FL) last … Read more

These 3 stocks are struggling, but I’m not ready to give up

These 3 stocks are struggling, but I’m not ready to give up

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE If you had told me that club names Estee Lauder ( EL ) or Danaher ( DHR ) would ever miss their spots not once, but twice, I would have told you to get your head checked. These are companies that create and drive, which is … Read more

Investors buying another round in this pub and hotel group shouldn’t be a cat

Investors buying another round in this pub and hotel group shouldn’t be a cat

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE While management won’t be short-sighted or stupid enough to do an asset buyback, numbers like these should help support the share price, while any ongoing trading improvement, strike or not, could help point to upside potential. During this time, investors can pocket a … Read more

Investing Club meeting recap: Profit on bookings remains prudent as Wall Street rallies

Investing Club meeting recap: Profit on bookings remains prudent as Wall Street rallies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Big Winners Book Profits Emerson Captures Rise Humane Shares Stabilize 1 Wall Street’s big winners book profits rose Thursday, led by … Read more

The homebuilder’s stock has taken a hit, but it may still appeal to value seekers

The homebuilder’s stock has taken a hit, but it may still appeal to value seekers

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Again, none of this is a shock. However, the stock is still suffering as the statement came out on the same day as the the latest data on wage growth from the Office for National Statistics. They were much stronger than economists had … Read more

The technology sub-division is said to be worth $1 trillion. But taboos hold him back

The technology sub-division is said to be worth  trillion.  But taboos hold him back

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Investors are ignoring a huge tech sub-sector because it’s considered “taboo” — despite the fact that it’s set to be valuable 1 trillion dollars by 2027. The FemTech sector includes all innovations aimed at solving health problems that are only, differently or disproportionately suffered by women. … Read more

Cramer Says He’ll Buy This Leading Medical Tech Stock—Wish He Could Buy Stocks Too

Cramer Says He’ll Buy This Leading Medical Tech Stock—Wish He Could Buy Stocks Too

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Shares of GE Healthcare ( GEHC ) are falling on Thursday, giving club members a chance to invest in the medical technology company at an increasingly attractive price. Sellers are making a mistake on Thursday and we would be taking advantage of their misjudgment if it … Read more

This UK fund has dramatically outperformed its benchmark since new management took over

This UK fund has dramatically outperformed its benchmark since new management took over

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE A change in management can have a major impact on a company’s performance. For mutual funds, a new portfolio manager can introduce a very different investment approach and strategy that causes a significant movement in the share price. Indeed, Edinburgh Investment Trust changed … Read more

The UK’s energy network operator is in a strong position in the race for capital returns

The UK’s energy network operator is in a strong position in the race for capital returns

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Lower interest rates are likely to weigh on bond yields, and lower bond yields could increase the relative appeal of high dividends from stocks. National Grid remains the main income earner. Questor says: HOLD Designation: NG Closing share price: £10.62 Update: Polymetal This … Read more

Net cash positions are the foundation of future growth in these stocks

Net cash positions are the foundation of future growth in these stocks

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Indeed, their capital gain of 80 percent highlights the potential for high returns from the small-cap segment of the stock market. Given that the company has a solid balance sheet to help it weather an uncertain economic environment, as well as a sound … Read more

Illumina shareholders vote to appoint Carl Icahn board nominee, remove chairman

Illumina shareholders vote to appoint Carl Icahn board nominee, remove chairman

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Rafael Henrique | Lightrocket | Getty Images Activist investor Carl Icahn got enough support on Thursday Illumina shareholders to place one of his three nominees on the biotech company’s board of directors. Shareholders also ousted CEO John Thompson. An Illumina spokesman said a new board chairman … Read more

How UnitedHealth Group Became Bigger Than the Nation’s Biggest Banks

How UnitedHealth Group Became Bigger Than the Nation’s Biggest Banks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE UnitedHealth Group has the highest price per share of any company on the Dow Jones Industrial Average and is the tenth-heaviest stock on the S&P 500. In fact, UnitedHealth is not only the largest healthcare conglomerate in the United States by market cap and revenue, it’s … Read more

We are opening a new position at one of the big three medical imaging and diagnostics companies

We are opening a new position at one of the big three medical imaging and diagnostics companies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE This company operates in an addressable market worth $84 billion, which is expected to grow to approximately $100 billion by 2024. MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

This insurance company has the potential to increase profits in times of fear of inflation

This insurance company has the potential to increase profits in times of fear of inflation

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Year-to-date in 2023, Beazley posted a $104 million profit for a return on investment of plus 1.2 percent, compared to a $92 million loss and a return of minus 1.2 percent in the first three months of 2022. Finally, management seems confident in … Read more

This stock’s 40 percent drop represents an opportunity to bet on the recovery of e-commerce

This stock’s 40 percent drop represents an opportunity to bet on the recovery of e-commerce

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE They are up 66 per cent compared to a rather paltry 5 per cent increase for the FTSE 100. Further capital gains and stock market performance are ahead in our view for a number of reasons. After the fall, the company’s shares are … Read more

It is painful for some to admit, but this stock remains the main source of income

It is painful for some to admit, but this stock remains the main source of income

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE To get past all of this, it may be easiest to look at net income or after-tax income. In the first quarter, Shell reported a net profit of $8.7 billion, compared with $7.1 billion a year ago. This increase may seem unusual given … Read more

Lloyds has shrunk back to health and appeals to both income hunters and value seekers

Lloyds has shrunk back to health and appeals to both income hunters and value seekers

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Loan impairments, litigation and restructuring – items that have cost the bank £43bn since January 2013, compared with reported pre-tax income of £41bn in the same period – totaled just £274m as the bank kept a clean slate. Yes, bad loan expenses rose … Read more

Johnson & Johnson’s consumer health unit Kenvue has started trading. What this means for J&J shareholders like us

Johnson & Johnson’s consumer health unit Kenvue has started trading.  What this means for J&J shareholders like us

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson’s ( JNJ ) consumer health unit Kenvue ( KVUE ) jumped more than 22% in its first day of trading Thursday, putting the Club holding company one step closer to finalizing its business separation. The planned split, which is slated for later this … Read more

We’re sticking with dividend stocks—other income-seeking investors should do the same

We’re sticking with dividend stocks—other income-seeking investors should do the same

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE The energy storage technologies it invests in help power grids manage short-term spikes in supply and demand. This is likely to become increasingly important as relatively unreliable renewable energy sources such as wind farms and electric vehicles, which place greater demand on the … Read more

J&J’s consumer health spinoff Kenvue opens at $25.53, up 16%, in public debut

J&J’s consumer health spinoff Kenvue opens at .53, up 16%, in public debut

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc., a Johnson & Johnson consumer health company, pose together during the company’s IPO on the New York Stock Exchange (NYSE) in New York, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & JohnsonKenvue’s consumer health … Read more

J&J’s consumer health company, Kenvue, will go public this week. Here’s what you need to know

J&J’s consumer health company, Kenvue, will go public this week.  Here’s what you need to know

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnsonconsumer health company, Kenvueexpected this week in the largest US IPO in more than a year. this business it’s full of household names familiar to investors and … Read more

Carl Icahn calls Illumina’s Q1 results “very disappointing,” sharply lowers plan

Carl Icahn calls Illumina’s Q1 results “very disappointing,” sharply lowers plan

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A. Grogan | CNBC Carl Icahn called on Friday Illuminina the first quarter the results “very disappointing” and criticized the DNA sequencing company new plans reduce costs. The activist investor, who owns … Read more

Admiral’s strong finances and growing customer base provide the ammunition to help it sail higher

Admiral’s strong finances and growing customer base provide the ammunition to help it sail higher

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Pre-tax profit for the year was down 39 per cent year-on-year (and even 7 per cent lower than in 2019 before Covid), thanks to increased claims and how inflation pushed up the cost of car repairs. Direct Line’s dividend cut and then the … Read more

The outlook for this stock may be dim, but there is still hope for an exciting turnaround

The outlook for this stock may be dim, but there is still hope for an exciting turnaround

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE A market capitalization of £153m looks low compared to consensus sales forecasts of £724m, even after adjusting for cash, debt and leases, while a share price of 160p would look tempting if earnings per share close to the previous peak in 2020 at … Read more

Johnson & Johnson’s consumer health unit is valued at $40 billion before the IPO, the report said

Johnson & Johnson’s consumer health unit is valued at  billion before the IPO, the report said

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson logo SOPA Images | LightRocket | Getty Images Johnson & JohnsonThe consumer health business is valued at $40 billion before his First public offering later this year, according to the report The Wall Street Journal. Future spinoff Kenvue plans to raise $3.5 billion … Read more

Abbott Labs shares jump as revenue, earnings defy steep drop in Covid test sales

Abbott Labs shares jump as revenue, earnings defy steep drop in Covid test sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Abbott manufacturing facility in Sturgis, Michigan on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Company shares Abbott Laboratories fell on Wednesday after the company’s earnings and revenue beat Wall Street expectations, despite a dramatic slowdown in sales of its Covid-19 tests. The medical … Read more

California and other western states lead in unhealthy levels of air pollution, report shows

California and other western states lead in unhealthy levels of air pollution, report shows

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Smoke hangs over the Oakland-San Francisco Bay Bridge in San Francisco, California on Wednesday, September 9, 2020. David Paul Morris | Bloomberg | Getty Images California and other Western states are facing dirtier air quality from worsening heat, drought and wildfires, and communities of color are … Read more

J&J’s 2025 drug sales forecast shouldn’t shake investors. So much else is similar

J&J’s 2025 drug sales forecast shouldn’t shake investors.  So much else is similar

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Before the bell on Tuesday, Johnson & Johnson ( JNJ ) reported a strong first quarter, with sales up more than 5.5% and profit up year-over-year. Shares of the Dow component and Club holding should not lose 2.5% on such results. J&J’s first-quarter sales of $24.75 … Read more

Wall Street upgrades Emerson and Danaher as Apple expands in India. Here are the club stocks making headlines on Tuesday

Wall Street upgrades Emerson and Danaher as Apple expands in India.  Here are the club stocks making headlines on Tuesday

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Wall Street upgraded the Club’s two underperforming stocks — Emerson Electric ( EMR ) and Danaher ( DHR ) — to an equivalent buy rating on Tuesday. Meanwhile, longtime core holding company Apple ( AAPL ) has taken another step forward in the key global smartphone … Read more

Club meeting recap: Jim Cramer says Johnson & Johnson’s post-earnings sell-off is a mistake and a buying opportunity

Club meeting recap: Jim Cramer says Johnson & Johnson’s post-earnings sell-off is a mistake and a buying opportunity

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow Falls, Profits in Focus J & J Declines Missed Starbucks Undervalued? 1. Dow falls with earnings taking center stage Stocks … Read more

Moderna shares fell despite promising data from a cancer vaccine trial

Moderna shares fell despite promising data from a cancer vaccine trial

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sopa Images | Lightrocket | Getty Images Company shares Modern fell on Monday as Wall Street chewed on new trial results for a personalized cancer vaccine it is developing Merck. Merck shares were relatively flat. An experimental mRNA vaccine combined with Merck’s blockbuster drug Keytruda reduced … Read more

This very cheap stock is making the most of the downturn in the real estate market

This very cheap stock is making the most of the downturn in the real estate market

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE It is clear that its recent acquisitions have not yet reached their full potential. The bad mood in the industry caused a drop in commercial real estate prices, which contributed to a 3% drop in Urban Logistics’ net tangible assets per share in … Read more

Buy that confidence while investor fear is temporarily high

Buy that confidence while investor fear is temporarily high

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE While its dividend yield currently sits at a rather low 2.2 percent, shareholder payouts have grown by 5.2 percent per year over the past four years. A similar rate of growth is likely to beat inflation in the coming years as the full … Read more

As the global economic outlook improves, now is the time to invest in this provider of assurances and reviews

As the global economic outlook improves, now is the time to invest in this provider of assurances and reviews

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE The FTSE 100 company’s earnings per share figure fell by 20 percent in the 2020 financial year and has yet to fully recover. This resulted in a disappointing share price In April 2020, Questor advised readers to avoid itwith its market value falling … Read more

Watch out for gold as it surges towards record highs. Stocks offer better long-term prospects

Watch out for gold as it surges towards record highs.  Stocks offer better long-term prospects

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Of course, gold has proven to be an excellent holding in this column’s portfolio for wealth preservation. It has generated a return of 24 percent since its addition in April 2021. But now its projected returns are likely to be more limited due … Read more

Carl Icahn Says Illumina’s Appeal of FTC Order to Divest Grail ‘Nearly Impossible Battle’

Carl Icahn Says Illumina’s Appeal of FTC Order to Divest Grail ‘Nearly Impossible Battle’

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn, Chairman of Icahn Enterprises Holdings Scott Eelis | Bloomberg | Getty Images Carl Icahn said on Wednesday Illuminaappeal efforts order of the Federal Trade Commission divesting the highly contested Grail acquisition “is an almost impossible battle.” Ilumina told CNBC on Monday that it plans … Read more

Biden EPA cracks down on mercury pollution from power plants

Biden EPA cracks down on mercury pollution from power plants

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Michael Regan, administrator of the Environmental Protection Agency (EPA), speaks during an event at EPA headquarters in Washington, DC, U.S., Monday, Dec. 20, 2021. Samuel Corum | Bloomberg | Getty Images The Environmental Protection Agency said Wednesday it will tighten restrictions on several toxic air pollutants … Read more

Bubbles can change, but their development remains fairly consistent – ​​here’s how to spot the signs

Bubbles can change, but their development remains fairly consistent – ​​here’s how to spot the signs

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Details may change from bubble to bubble, but human behavior does not, and the order is consistent. The starting point for a bubble is a new investment opportunity that may be real, or even with a grain of truth large enough to be … Read more

Bubbles can change, but their development remains fairly consistent – ​​here’s how to spot the signs

Bubbles can change, but their development remains fairly consistent – ​​here’s how to spot the signs

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Bubbles can change, but their development remains fairly consistent – ​​here’s how to spot the signs. MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE

With a well-supported balance sheet and a hefty land bank, this builder’s foundation is solid

With a well-supported balance sheet and a hefty land bank, this builder’s foundation is solid

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Data published by the Bank of England last week showed 43,500 approved mortgage loans in Februaryfrom 39,600 in January to provide a glimmer of hope and support Bellway’s impression of the market. That doesn’t mean investors should get complacent. Mortgage approvals peaked at … Read more

FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail

FTC orders Illumina to divest .1 billion acquisition of cancer test developer Grail

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Francis deSouza, Chief Executive Officer of Illumina Inc., during a panel session on Day Three of the World Economic Forum (WEF) in Davos, Switzerland, Thursday, January 19, 2023. Stefan Wermuth | Bloomberg | Getty Images The Federal Trade Commission ordered on Monday Illumina to divest its … Read more

Carl Icahn slams Illumina for nearly doubling CEO pay despite plummeting market value

Carl Icahn slams Illumina for nearly doubling CEO pay despite plummeting market value

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A. Grogan | CNBC Carl Icahn damn it Illumina for nearly doubling its CEO’s pay last year despite the biotech company’s dramatic drop in market value since the controversial deal. “I would … Read more

Ilumina urges shareholders to reject Carl Icahn’s board nominees as proxy battle heats up

Ilumina urges shareholders to reject Carl Icahn’s board nominees as proxy battle heats up

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Rafael Henrique | Lightrocket | Getty Images Illumina urged shareholders on Thursday to reject Carl Icahn’s three board nominees at this year’s annual meeting, saying they would “jeopardize the progress” of the biotech company’s core business. “Carl Icahn’s involvement with Illumina threatens the company’s long-term success, … Read more

This large-cap fund’s 40 years of continuous dividend growth underscores its income appeal

This large-cap fund’s 40 years of continuous dividend growth underscores its income appeal

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE This column first advised readers in February 2020 to buy Merchants, which focuses on UK-listed large-cap stocks. Even after the stock market crash caused by the pandemic and the current period of investor doom and gloom, the equity posted an 11% return from … Read more

Carl Icahn wants to bring back former Illumina CEO ‘immediately’ as battle for brokers intensifies

Carl Icahn wants to bring back former Illumina CEO ‘immediately’ as battle for brokers intensifies

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A. Grogan | CNBC Carl Icahn said Wednesday the biotech company Illumina should “immediately” bring back its former CEO, its latest move va a battle for middlemen ensues with a biotechnology company. … Read more

Our property portfolio is diverse, but this stock may be something to build on

Our property portfolio is diverse, but this stock may be something to build on

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE British Land’s £6.6bn portfolio offers a wide range of exposure to UK properties, in retail parks, shopping centres, city warehouses and what management calls “campuses”, such as Canada Water and Broadgate in London, where they combine offices, shops and leisure time. New developments … Read more

Shares of this bank seem cheap, but the atmosphere of fear in the sector is causing a headache

Shares of this bank seem cheap, but the atmosphere of fear in the sector is causing a headache

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Instead, investors are either avoiding the banking sector entirely or, if they retain exposure, do so through megabanks, not challengers, and seek broad-based banking (retail and commercial) rather than exposure to specific niches, however carefully managed and profitable they may be. Investment banking … Read more

Shares of BioNTech slipped on gloomy outlook for Covid vaccine sales

Shares of BioNTech slipped on gloomy outlook for Covid vaccine sales

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Vials of the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are shown before use at a mobile vaccine clinic in Valparaiso, Chile, on January 3, 2022. Rodrigo Garrido | Reuters Company shares BioNTech slipped more than 6% in morning trading on Monday after the German drugmaker … Read more

Carl Icahn claims Illumina executives got extra insurance to close ‘disastrous’ $7.1 billion Grail deal

Carl Icahn claims Illumina executives got extra insurance to close ‘disastrous’ .1 billion Grail deal

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn made the claim on Friday IlluminaCompany executives required additional personal liability insurance before the biotech firm signed off on a $7.1 billion purchase of cancer test developer Grail in 2021. The claim is the latest development in the the emerging battle for brokers between … Read more

In the long term, these two VC funds are still worth holdings

In the long term, these two VC funds are still worth holdings

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE As well as their focus on investing in unlisted and Aim-listed smaller companies lacking the geographic diversification or balance sheet strength of larger firms, VCTs may be relatively illiquid. They also tend to pay “flat” dividends because their payouts are at least partially … Read more

Sanofi and Regeneron shares rise more than 6% after data suggests asthma drug Dupixent can also treat COPD

Sanofi and Regeneron shares rise more than 6% after data suggests asthma drug Dupixent can also treat COPD

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The logo at the Sanofi booth at the Viva Technology conference dedicated to innovation and startups at the Porte de Versailles exhibition center in Paris, France, on June 15, 2022. Benoît Tessier | Reuters Company shares Sanofi and Regeneron both jumped more than 6% on Thursday, … Read more

For investors looking for solid ground in an uncertain market, the balance sheet is king

For investors looking for solid ground in an uncertain market, the balance sheet is king

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Amid continued market volatility and renewed fears about the health of the banking sector, investors and analysts are increasingly targeting stocks of companies with excellent balance sheets. Eleven Club holdings stand out, with chipmaker Nvidia ( NVDA ) and Google parent Alphabet ( GOOGL ) at … Read more

Biotech company Illumina is refusing to fight Carl Icahn’s proxy over the $7.1 billion Grail deal

Biotech company Illumina is refusing to fight Carl Icahn’s proxy over the .1 billion Grail deal

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Carl Icahn Adam Jeffery | CNBC A biotech company Illumina on Monday fended off a fight against Carl Icahn’s agent over a takeover of cancer test developer Grail, saying candidates for the activist investor’s board “do not add value.” A DNA sequencing company based in San … Read more

An improving outlook for emerging markets means that confidence deserves more time to take hold

An improving outlook for emerging markets means that confidence deserves more time to take hold

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE According to reports economist John Maynard Keynes, “in the long run we are all dead”. Indeed, investors do not have an infinite amount of time to build wealth before retirement, and ultimately death inevitably occurs. This means that their investment portfolio must deliver … Read more

Why are bank stocks falling? The role of Credit Suisse and what you need to do

Why are bank stocks falling?  The role of Credit Suisse and what you need to do

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Barclays was probably among the hardest hit by SVB’s collapse because of its US exposure and its Barclays Capital division, Mr Burgeman said. Its shares have fallen 18 per cent in the past week, while falls in Lloyds and NatWest were less steep … Read more

Cocaine production is at an all-time high, the UN says

Cocaine production is at an all-time high, the UN says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A report by the United Nations Office on Drugs and Crime notes that cocaine production is at an all-time high, with demand rising again after the pandemic and new hubs of the trade emerging. The UN Global Report on Cocaine 2023 states that in the past … Read more

As the collapse of the SVB heralds the end of the era of free money, investors must stick to their disciplines

As the collapse of the SVB heralds the end of the era of free money, investors must stick to their disciplines

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Finally, shares are only back to where they were in January, as are the other big FTSE 100 banks, apart from Barclays, which is hiding at levels last seen in November. This is not to say that shareholders can be complacent, particularly in … Read more

Biden proposes first national restrictions on toxic ‘forever chemicals’ in drinking water

Biden proposes first national restrictions on toxic ‘forever chemicals’ in drinking water

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Environmental Protection Agency headquarters in Washington, DC, USA on January 19, 2020. Lucy Nicholson | Reuters The Environmental Protection Agency is on Tuesday proposed the first nationwide restrictions about the so-called “forever chemicals” in drinking water after discovering that the compounds are more dangerous than previously … Read more

Shares of Moderna rose 7% after Cowen raised the stock and said it would be a “leader” in RSV vaccines

Shares of Moderna rose 7% after Cowen raised the stock and said it would be a “leader” in RSV vaccines

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A healthcare worker prepares a syringe of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the COVID-19 pandemic in Manhattan, New York, on January 29, 2021. Mike Segar | Reuters Shares of Moderna jumped nearly 7% on Wednesday after … Read more

Pfizer’s CEO says $43 billion deal will allow him to offer Seagen’s cancer therapy on a scale never seen before

Pfizer’s CEO says  billion deal will allow him to offer Seagen’s cancer therapy on a scale never seen before

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pfizer CEO Albert Bourla speaks with the President of the European Commission during a press conference after a visit to monitor the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of the US pharmaceutical company Pfizer in Puurs on April 23, 2021. Your John | … Read more

WeightWatchers shares soar 70% after company agrees to buy obesity treatment platform

WeightWatchers shares soar 70% after company agrees to buy obesity treatment platform

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Weight Watchers ice cream in a supermarket freezer in New York. Richard Levine | Corbis News | Getty Images Company shares WW Internationalalso known as WeightWatchers, jumped sharply on Tuesday after the company said it plans to buy Sequence, a telehealth platform that provides obesity treatments. … Read more

When quality stocks go on sale in the rough market, we love to go shopping. Here is our latest purchase

When quality stocks go on sale in the rough market, we love to go shopping.  Here is our latest purchase

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE After keeping our powder dry since the end of February, we’ll be doing a little weakness shopping on Tuesday. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Jim Cramer’s Investment Club meeting on Monday: Fed and jobs, China reopening, Eli Lilly

Jim Cramer’s Investment Club meeting on Monday: Fed and jobs, China reopening, Eli Lilly

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Fed and Jobs Report Stick with China Stocks Reopen Watch Eli Lilly 1. Fed and Jobs Report Stocks traded higher on … Read more

Don’t be tempted by cash savings – this trust offers much better prospects for income investors

Don’t be tempted by cash savings – this trust offers much better prospects for income investors

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE clear, dividend growth that exceeds inflation it is never guaranteed. While the current downturn is unlikely to last forever, estimating when a recovery will occur that will fuel higher profits and rising shareholder payouts is not an exact science. In addition, the fund’s … Read more

Watch live: Biden warns of GOP plans to limit access to health care

Watch live: Biden warns of GOP plans to limit access to health care

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE (The stream is scheduled to begin at 3 p.m. ET. Refresh the page if you don’t see the video above at that time.) US President Joe Biden will sharply criticize Republican policy in a Tuesday afternoon speech in Virginia Beach, where he will point out the … Read more

Op-ed: DEA and FDA rules increase Adderall shortages

Op-ed: DEA and FDA rules increase Adderall shortages

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Adderall XR 30mg Tablets by Shire Plc. JB Reed | Bloomberg | Getty Images Josh Disbrow is the President and Chief Executive Officer of Aytu BioPharma, which makes a competing ADHD drug called Adzenys XR-ODT. A nationwide Adderall shortage which makes many sufferers struggle to manage … Read more

The Buffett Test: This chart shows how much each holding club spends on stock buybacks

The Buffett Test: This chart shows how much each holding club spends on stock buybacks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE When Warren Buffett talks, Wall Street listens — and the “Oracle of Omaha” issued a full-throated defense of stock buybacks in his latest annual letter to Berkshire Hathaway shareholders. That’s why we’re spotlighting Club holdings that buy back the most stocks, including Morgan Stanley ( MS … Read more

Amazon, Wells Fargo, Microsoft, Nvidia make headlines. Here’s our take on the news

Amazon, Wells Fargo, Microsoft, Nvidia make headlines.  Here’s our take on the news

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Club holdings Amazon ( AMZN ) , Wells Fargo ( WFC ) and Nvidia ( NVDA ) and Microsoft ( MSFT ) are in the news on Wednesday. Here are the headlines and implications for the club’s investment thesis. Amazon Closes Healthcare Deal AMZN YTD mountain … Read more

Tuesday’s choppy stock market gives us an opportunity to add to the health stock that is appropriate for this environment

Tuesday’s choppy stock market gives us an opportunity to add to the health stock that is appropriate for this environment

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A sell-off in the market creates an opportunity to buy shares of companies that are doing well and will thus be in a recession. . MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Source

Why now is a great time to buy US stocks

Why now is a great time to buy US stocks

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Over the past decade, its 14.8% annualized return is 2.7 percentage points higher than the 12.1% compounded return produced by its benchmark index, the Russell 2000 Index. The fund’s outlook is closely tied to the outlook for the US economy because smaller companies … Read more

Why Shell shares can look cheap

Why Shell shares can look cheap

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE Weakness in gas may be one of the reasons analysts see Shell’s earnings falling in 2023 and 2024. However, the natural tendency of this column is to challenge the consensus, and while the recession, the short-term tendency to curb energy consumption and the … Read more

A look under the hood is enough to show that Auto Trader has the power to handle the latest crisis

A look under the hood is enough to show that Auto Trader has the power to handle the latest crisis

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE In fact, about 92 percent of new cars are purchased through financing each year. With the cost of borrowing rising rapidly and replacing an existing car being generally considered by most consumers to be a discretionary purchase rather than an essential purchase, it … Read more

Jim Cramer’s Investment Club Meeting Thursday: Meta, Eli Lilly, Estee Lauder

Jim Cramer’s Investment Club Meeting Thursday: Meta, Eli Lilly, Estee Lauder

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. Don’t Sell the Mint Look past Eli Lilly’s tough quarter. Opportunity to buy Estee Lauder 1. Don’t sell Meta. Shares of … Read more

An excellent history and a big discount mean an attractive buying opportunity

An excellent history and a big discount mean an attractive buying opportunity

MY NUMBER 1 RECOMMENDATION TO CREATE FULL TIME INCOME ONLINE: CLICK HERE With a gearing of 8 per cent, its share price is likely to be more volatile than the FTSE 250 in the short-term. But for long-term investors, gearing increases positive returns in a stock market that is likely to rise and recover to … Read more